Matthew Agee MD
Radiology/Nuclear Medicine, Weill Cornell Imaging - New York Presbyterian Hospital
Join to View Full Profile
525 E 68th StNew York, NY 10065
Phone+1 212-746-6000
Dr. Agee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine, 2019 - 2022
Zucker School of Medicine at Hofstra/Northwell at Mather HospitalInternship, Internal Medicine, 2018 - 2019
St. George's University School of MedicineClass of 2018
Certifications & Licensure
NY State Medical License 2022 - 2026
American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and Future Horizons.Divya Yadav, Elisabeth O'Dwyer, Matthew Agee, Silvina P Dutruel, Sonia Mahajan
Journal of Imaging. 2025-02-17 - [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases.Jana Ivanidze, Arman Sharbatdaran, Aliah McCalla, Andrew Brandmaier, Eleni Andreopoulou
European Journal of Radiology. 2024-12-01 - 5 citationsImaging with [Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial.Salomon Tendler, Mark P Dunphy, Matthew Agee, Joseph O'Donoghue, Rania G Aly
The Lancet. Oncology. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
